相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infuse-as-you-go convective delivery to enhance coverage of elongated brain targets: technical note
Vivek Sudhakar et al.
JOURNAL OF NEUROSURGERY (2020)
Trophic factors for Parkinson's disease: Where are we and where do we go from here?
Gesine Paul et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
Chadwick W. Christine et al.
ANNALS OF NEUROLOGY (2019)
Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease
John D. Heiss et al.
MOVEMENT DISORDERS (2019)
Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy
Robert E. Gross et al.
ANNALS OF NEUROLOGY (2018)
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease
Stephane Palfi et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Treatment of Drug-Resistant Epilepsy
Joon Y. Kang et al.
NEUROTHERAPEUTICS (2017)
Exploring Break's Hypothesis of Parkinson's Disease
Carmen D. Rietdijk et al.
FRONTIERS IN NEUROLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial
Agnieszka Ciesielska et al.
PLOS ONE (2017)
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease
Martin Niethammer et al.
JCI INSIGHT (2017)
AAV viral vector delivery to the brain by shape-conforming MR-guided infusions
Krystof S. Bankiewicz et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Intraoperative MRI for deep brain stimulation lead placement in Parkinson's disease: 1 year motor and neuropsychological outcomes
Christos Sidiropoulos et al.
JOURNAL OF NEUROLOGY (2016)
Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease
Jill L. Ostrem et al.
JOURNAL OF NEUROSURGERY (2016)
395. OXB-102: An Enhanced Gene Therapy for Parkinson's Disease
MOLECULAR THERAPY (2016)
Surgical implantation of STN-DBS leads using intraoperative MRI guidance: technique, accuracy, and clinical benefit at 1-year follow-up
Stephan Chabardes et al.
ACTA NEUROCHIRURGICA (2015)
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
C. Warren Olanow et al.
ANNALS OF NEUROLOGY (2015)
Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
R. T. Bartus et al.
NEUROBIOLOGY OF DISEASE (2015)
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stephane Palfi et al.
LANCET (2014)
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
Raymond T. Bartus et al.
NEUROLOGY (2013)
Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
Gabriele Mittermeyer et al.
HUMAN GENE THERAPY (2012)
Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
Minyoung Oh et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
Adrian P. Kells et al.
NEUROBIOLOGY OF DISEASE (2012)
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A. LeWitt et al.
LANCET NEUROLOGY (2011)
Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia
Agnieszka Ciesielska et al.
MOLECULAR THERAPY (2011)
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
R. Mark Richardson et al.
MOLECULAR THERAPY (2011)
Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
R. Mark Richardson et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2011)
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Adrian P. Kells et al.
JOURNAL OF NEUROSCIENCE (2010)
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
William J. Marks et al.
LANCET NEUROLOGY (2010)
Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
Xiaomin Su et al.
MOLECULAR THERAPY (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
Shin-ichi Muramatsu et al.
MOLECULAR THERAPY (2010)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
C. W. Christine et al.
NEUROLOGY (2009)
Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery
Vanja Varenika et al.
JOURNAL OF NEUROSURGERY (2008)
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
William J. Marks et al.
LANCET NEUROLOGY (2008)
Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum
Christopher D. Herzog et al.
MOLECULAR THERAPY (2008)
GENE AND CELL DELIVERY TO THE DEGENERATED STRIATUM: STATUS OF PRECLINICAL EFFORTS IN PRIMATE MODELS
R. Mark Richardson et al.
NEUROSURGERY (2008)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G. Kaplitt et al.
LANCET (2007)
A dose-ranging study of AAV-hAADC therapy in parkinsonian monkeys
John R. Forsayeth et al.
MOLECULAR THERAPY (2006)
The perivascular pump driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain
P Hadaczek et al.
MOLECULAR THERAPY (2006)
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain
R Saito et al.
EXPERIMENTAL NEUROLOGY (2005)
Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen
MT Krauze et al.
EXPERIMENTAL NEUROLOGY (2005)
Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents - Technical note
MT Krauze et al.
JOURNAL OF NEUROSURGERY (2005)
AAV2-mediated gene delivery to monkey putamen: Evaluation of an infusion device and delivery parameters
LM Sanftner et al.
EXPERIMENTAL NEUROLOGY (2005)
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging
R Saito et al.
CANCER RESEARCH (2004)
The primate basal ganglia: parallel and integrative networks
SN Haber
JOURNAL OF CHEMICAL NEUROANATOMY (2003)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Convection-enhanced delivery of AAV vector in parkinsonian monkeys;: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
KS Bankiewicz et al.
EXPERIMENTAL NEUROLOGY (2000)
分享论文
